- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 1/10 - Laxatives
Patent holdings for IPC class A61P 1/10
Total number of patents in this class: 480
10-year publication summary
|
20
|
28
|
40
|
39
|
47
|
37
|
31
|
38
|
25
|
13
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2721 |
14 |
| Norgine BV | 42 |
10 |
| Raqualia Pharma Inc. | 122 |
9 |
| The Regents of the University of California | 20556 |
8 |
| N.V. Nutricia | 1094 |
8 |
| Enterin, Inc. | 43 |
8 |
| Ironwood Pharmaceuticals, Inc. | 156 |
7 |
| Renexxion, LLC | 15 |
7 |
| Kyowa Chemical Industry Co., Ltd. | 67 |
6 |
| Ardelyx, Inc. | 115 |
5 |
| Dark Canyon Laboratories, LLC | 10 |
5 |
| Sumitomo Dainippon Pharma Co., Ltd. | 211 |
5 |
| Neilos S.r.l. | 84 |
5 |
| Taejoon Pharmaceutical Co., Ltd. | 22 |
5 |
| Azurity Pharmaceuticals, Inc. | 251 |
5 |
| Serleva, Inc. | 5 |
5 |
| Braintree Laboratories, Inc. | 14 |
4 |
| CJ Cheiljedang Corporation | 3568 |
4 |
| Dignify Therapeutics, LLC | 17 |
4 |
| Meiji Co., Ltd. | 738 |
4 |
| Other owners | 352 |